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Abstract.  Carbon tetrachloride (CCL) treatment of 
rats produces an early defect in methylation of hepato- 
cyte ribosomal RNA, which occurs concurrently with 
a defect in the protein synthetic capacity of isolated 
ribosomes. The CCh-induced methylation defect is 
specific for the 2'-O-ribose position, and a correspond- 
ing proportional increase in mTG base methylation oc- 
curs in vivo.  Undermethylated ribosomal subunits 
(rRNA) from CCl4-treated preparations can be methyl- 
ated in vitro to a much greater extent than those from 
control preparations,  and in vitro methylation restores 
their functional capacity.  In vitro methylation of treated 
ribosomal subunits (which restores functional capacity) 
occurs at 2'-O-ribose positions (largely G  residues).  In 
contrast,  in vitro methylation of control ribosomal 
subunits (which does not affect functional activity) 
represents base methylation as mTG, sites which are 
apparently methylated in treated preparations  in vivo. 
Methylation/demethylation of 2'-O-ribose sites in rRNA 
exposed on the surface of cytoplasmic ribosomal sub- 
units may represent an important cellular mechanism 
for controlling protein synthesis in quiescent hepato- 
cytes, and it appears that CCL disrupts protein synthe- 
sis by inhibiting this 2'-O-ribose methylation. 
C 
ARBON tetrachloride  (CCI4)  ~ has  long  served  as  a 
model compound for study of hepatic  injury (9, 36, 
37, 39, 46). Like many other agents, CCL is metab- 
olized via cytochrome P-450 (25, 39) to yield a free radical 
(34, 44, 45, 50, 51), which may mediate subsequent damage. 
A  number  of subcellular processes/compartments  are  af- 
fected (including  lipid peroxidation  and Ca  ++ influx),  and a 
well-described morphologic sequence ensues (39, 46), al- 
though the basic mechanisms  underlying the cellular injury 
are not clear (3, 40 53). 
Early studies established  the endoplasmic reticulum  (ER) 
as the site of the first significant cellular changes (38, 39, 46). 
Altered ER structure occurs by 30 rain after oral CC14 ad- 
ministration  (46, 47) and consists  chiefly of a marked loss 
of ribosomes from rough ER ("degranulation')  and a dis- 
aggregation  of polysomes. Slightly later, other morphologi- 
cal changes  in ER (such as tubular aggregates)  can be de- 
tected. 
The major early functional defect involves protein synthe- 
sis (47); alterations in protein synthesis are specific for hepa- 
tocytes and parallel morphological alterations within the lob- 
ules (24).  The nature of the protein synthetic  defect is not 
Address correspondence and reprint requests to Dr. Clawson at Department 
of Pathology, 502  Ross Hall,  George Washington University, 2300  Eye 
Street N.W.,  Washington DC 20037. 
1.  Abbreviations  used  in  this  paper:  AdoMet,  S-adenosyl-methionine; 
CCI,, carbon tetrachloride; ER, endoplasmic reticulum. 
clear.  Microsomes and ribosomes isolated after CCh intox- 
ication  show significantly decreased protein synthesis (47), 
while the respective soluble cell-sap fractions  appear to be 
equally efficacious in supporting in vitro incorporation (46); 
the changes do not involve alterations in amino acid pools or 
uptake  (48). 
The  CCh-induced  breakdown  of polysomes might  in- 
volve alterations  in mRNAs, or may reside in the ribosomal 
subunits. More specifically, translatability  of mRNA is regu- 
lated by methylation  in "cap" structures  (27), and changes in 
methylation of ribosomal subunits have been related to func- 
tional changes in protein synthesis (13, 15, 18, 28, 31-33, 43, 
49, 52). We therefore explored the possibility that alterations 
in RNA methylation may underlie the early defect in protein 
synthesis  after CC14 administration. 
Materials and Methods 
Male Sprague-Dawley rats that weighed 250-300 g were used. CC14 was 
administered at 0.25 ml/100 g body weight with an equal volume of mineral 
oil by stomach tube. For methylation studies, rats were given CC~4; 0.5 h 
later,  they were given  1.6 mCi  [3H]methyl-L-methionine (New England 
Nuclear,  Boston,  MA,  70-85  Ci/mol  in  H20;  or  Amersham  Corp., 
Arlington Heights, IL, 87 Ci/mol in 70%  ethanol) intraperitoneally. After 
an additional 1-h labeling period, they were killed. For initial time course 
experiments, rats were given 0.25 mCi [3H]methylmethionine at 0.5 h after 
CCh administration, and labeling was for 1, 2, or 4 h. For some compara- 
tive studies using the acute-phase response, rats were given 0.25 mi turpen- 
tine/100 g body weight subcutaneously, and were killed after various inter- 
vals (maximal levels of acute-phase reactant mRNAs occur after 36 h). 
Rat livers were removed and homogenized in 0.25 M STKM2 buffer (su- 
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5 mM  MgC12,  2  mM  2-mercaptoethanol).  The  homogenate was  can- 
trifuged at 10,000 g for 10 min at 0°C. The supernatant fractions were further 
centrifuged at 105,000 g for 90 min at 4°C; the supernatant resulting from 
this centrifugation, designated as S100, was adjusted to 30 or 5 mg pro- 
tein/ml (19) for subsequent use. The crude pellets were used for subsequent 
nuclear isolations. 
For preparation of ribosomes, sodium deoxycholate was added to the 
10,000 g supernate to a final concentration of 1%, and this was centrifuged 
at  105,000  g  for  120  min  at  4°C.  The  resultant  polysomal pellet was 
resuspended in 25 mM Tris-HCl, pH 7.4,  5 mM KCI,  1 mM MgC12, and 
adjusted to 6  mg protein/ml; treated and control suspensions contained 
equivalent quantities of poly(A)- RNA and mRNA.  For preparation of 
ribosomal subunits, polysomes were dissociated by incubation with puro- 
mycin (4). The dissociated subunits were then harvested by centrifugation 
at 60,000  g  for 16 h at 0°C. Ribosomal suspensions were fractionated on 
10-40% sucrose buffer gradients by centrifugation at 117,000 g for 2.5 h at 
4°C  (4).  The  subunits were harvested by centrifugation and  separately 
pooled. 
For analysis of in vitro protein synthesis, 60 gl of the ribosomal suspen- 
sion and 10 stl of S100 (at 5 mg/ml) were added to reaction mixtures (100 
gl) containing Tris-HCl, pH 8, 5 mM MgC12, 100 mM NI-hC1, 3.1 mM di- 
thiothreitol (DTT), 0.31 mM ATP, 0.31 mM GTP, and [14C]phenylalanine 
(in some experiments, poly(U) was added to 5 mg/ml). Incubations were 
for 30 rain, during which time incorporation was linear. After incubation, 
mixtures were precipitated on ice for 30 min in 10% TCA and collected on 
filters. These were rinsed with cold 5 % TCA, twice with absolute ethanol, 
once with ethanol/ether, once with ether; then dried, and counted in liquid 
scintillant. Translation of poly(A)  + mRNA purified from S100 fractions 
was performed with a  nuclease-treated rabbit reticulocyte lysate system 
(Bethesda Research Laboratories, Bethesda, MD) and [35S]methionine. 
For methylation studies, cytoplasmic RNA from the 10,000 g supernate 
was isolated by centrifugation through 5.7 M CsCI (8, 11); recovery oftRNA 
is <1%.  RNA was separated into poly(A)  + and poly(A)- fractions using 
LiC1 buffers and oligo(dT)-cellulose (23). In other experiments, cytoplas- 
mic poly(A)- RNA was fractionated on 5-25% STKM2 gradients by cen- 
trifugation at 117,000 g for 16 h at 4°C. The 28S and 18S ribosomal RNAs 
were collected and precipitated with ethanol. 
Crude  nuclear  pellets  from the  initial  10,000 g  centrifugation were 
resuspended by homogenization in 0.25  M  STKM2, nuclei were purified 
(1), and nucleoli were isolated (26). RNA was initially extracted with chlo- 
ropane (chloropane consists of equal volumes of phenol and chloroform, 
0.1% 8-hydroxyquinoline, saturated with ANE buffer, which consists of  0.01 
M  Na acetate, pH 6.0, 0.1 M  NaCI, and 1 mM EDTA), precipitated with 
ethanol, then digested with DNase I (Worthington Biochemical Corp., Free- 
hold, NJ) and subsequently with proteinase K (23), then reextracted and 
precipitated. Nucleolar and cytoplasmic RNA preparations were free of de- 
tectable DNA and protein, as assessed using standard assays (10, 19). 
Purified RNA fractions were then digested to nucleosides (6); 3 mg of 
RNA preparations were resuspended (2 ml) in 5 mM sodium acetate (pH 
5), heated to 95°C for 5 rain, and then rapidly cooled. 125 U of RNase T2 
(Bethesda Research Laboratories) and 40 U  of RNase P~ (Betbesda Re- 
search Laboratories) were added. After overnight incubation at 37°C, the 
pH of the mixture was adjusted to 9 by addition of ammonium acetate to 
10 mM, and 100 U of bacterial alkaline phosphatase (Bethesda Research 
Laboratories) were added and the mixture was again incubated overnight at 
37°C. This digestion resulted in products which were 100% soluble in TCA 
or ethanol. 
RNA digests were concentrated by lyophilization, resuspended in water, 
and fractionated using HPLC essentially as described for uncharged nucleo- 
sides (6).  We used a model No.  1084 HPLC (Hewlett-Packard Co., Palo 
Alto, CA), a reverse-phase  Partisil 50DS-3 column (Whatman Inc., Clifton 
NJ), and a linear 0-10% acetonitrile gradient in water over the initial 40 
min. Either 0.5- or 1-ml fractions were collected. An initial peak consisting 
of residual oligonucleotides was obtained in some experiments. In many 
cases, this peak was collected, lyophilized, and redigested as before, and 
then refractionated via HPLC. This resulted in conversion to nucleosides 
with chromatographic profiles analogous to the original patterns, showing 
that the variable quantity of oligonucleotides represented a random assort- 
ment of methylated nucleosides (in these cases, the counts were summed). 
In other experiments, gradient-purified ribosomal subunits were pre- 
pared as described; 20 pmol were mixed with various quantities of S100 and 
2.5  ltCi  [3H]methyl-labeled s-adenosyl-methionine (AdoMet;  New  En- 
gland Nuclear, 55-85 Ci/mmol, diluted to a specific activity of  0.5 Ci/mmol 
[13, 43,  49,  52];  standard aliquots contained  12  gg or 24  lxg ribosomal 
subunits, 1.5 I~g or 7.5 gg SI00 protein, and 1 nmol [3H]AdoMet). After 
various periods (0-40 min) at 37"C, the mixtures were extracted with chlo- 
ropane, and TCA-precipitable material was collected on filters, rinsed exten- 
sively,  and counted.  In other experiments, after methylation of isolated 
ribosomal subunits with [~H]AxloMet,  the subunits were precipitated in 
ethanol and resuspended in S100 fractions from control or treated animals. 
After various periods, the radioactivity remaining in the ribosomal RNA 
was quantitated as before. 
In other experiments, aliquots of 40  +  60S ribosomal subunits (90 ~tg 
protein) were methylated in vitro with unlabeled AdoMet (at 170 gm for 1× 
incubations, and also at 5 and 10×) in the presence of 300 I~g of SI00 pro- 
tein. After incubation at 35°C for 40 min, the mixtures were chilled and 
methylated ribosomal subunits were harvested by centrifugation at 105,000 g 
for 1 h. Aliquots were then resuspended with 1 lag of purified poly(A)+ 
mRNA, and protein synthesis was assessed as previously described with 
[t4C]phenylalanine. 
To examine the specificity of the in vitro methylation, purified 40S and 
60S ribosomal subunits from treated or control preparations were incubated 
in 10x  [3H]AdoMet (250 ~tCi, specific activity 60 Ci/mmol) with control 
S100 (200 ltg protein) for 30 min at 37°C. The mixtures were then extracted 
with chloropane and the aqueous phase was precipitated twice in ETOH. 
The pelleted RNA was then digested as described and examined via HPLC. 
Results 
In initial studies, we examined the time course of  methylation 
of cytoplasmic RNA fractions after various labeling periods, 
beginning 0.5  h  after CC14 intoxication (Fig.  1).  No  sig- 
nificant changes in methylation of poly(A)  + RNA were ob- 
served (Fig. 1, Table I), although the "degranulation" of ER 
was associated with a marked flux of functional poly(A)  + 
RNA into the S100 fraction (Fig. 2). In contrast, we observed 
marked changes in methylation of poly(A)- RNA. A maxi- 
mal (60%) decrease in methylation of cytoplasmic poly(A)- 
RNA occurred by 1.5 h after CC14 administration; this de- 
crease was maintained at 2.5 h, and the methylation  level was 
returning toward control levels at 4.5 h. The methylation de- 
fect paralleled the defect in protein synthesis noted under 
these conditions (see Fig.  1). 
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Figure 1.  Methylation of cytoplasmic RNA  fractions after CCh. 
[3H]Methylmethionine  was  administered  intraperitoneally  0.5  h 
after oral CC14 administration and animals were killed after vari- 
ous labeling intervals. Inset shows the linearity of incorporation of 
[3H]methyl groups into cytoplasmic poly(A)- RNA over the initial 
4-h period. Cytoplasmic RNA was fractionated into poly(A)  + and 
poly(A)-  fractions,  and  the  specific activities  of these fractions 
were  assessed.  The  fluctuations  in  poly(A)  +  labeling  were  not 
significantly  different  whereas  those  in  poly(A)-  were.  Also 
shown are the marked reductions in protein synthetic capacity of 
ribosomes isolated at various intervals after CCL intoxication. 
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RNA Fractions 
Cytoplasmic  Cytoplasmic  Nucleolar 
Sample  poly(A) + mRNA  poly(A)-  RNA  RNA 
cpm/#g  cpm/pg  cpm/#g 
Control  5.69  ±  0.03  3.91  ±  0.66  1.98  +  0.57 
Treated  5.27  ±  0.58  1.72  ±  0.88  4.68  ±  1.00 
Rats  were  given  0.25  ml  CC14 and  0.5  h  later,  they  received  [3H]methyl- 
methionine.  After  an  additional  1-h  labeling  period,  they  were  killed and 
cytoplasmic  and nucleolar RNAs were prepared. 
We  examined  the  methylation  defect  in  cytoplasmic 
poly(A)- RNA in more detail (see legend to Table I). The 
decreased specific activity of methylation of rRNA was most 
marked in 28S rRNA (1.92  +  0.29 vs. 0.82  +  0.17 cpm/gg), 
and a significant decrease was also noted in 18S rRNA (2.10 
-1- 0.30 vs.  1.37 +  0.14 cpm/lxg); the specific activity of the 
smaller RNA fraction (which includes 5.8S rRNA and pre- 
sumably poly(A)- mRNA)  was not changed (3.80  +  0.58 
vs. 3.43  +  0.43 cpm/Bg). We estimate that >90% of cyto- 
plasmic  poly(A)-  RNA  methylation  is  associated  with 
rRNA (see legend to Table I). 
We enzymatically degraded cytoplasmic poly(A)- RNA 
preparations, and analyzed the resulting products by HPLC 
(Fig. 3, Table II). The defect in methylation was specific for 
2'-O-ribose  methylation.  Control  preparations  contained 
76.7 +  4.8 % of label in 2'-O-ribose positions, whereas this 
decreased to 57.6 ±  3.5 % in treated preparations; these data 
imply  a  70%  decrease  in  total  2'-O-ribose  methylation. 
There was sparing of purine base methylation, with a greatly 
increased  proportion  of the  methylation  as  mTG  in  the 
treated fractions.  Subsequent experiments showed that the 
m7G was found only in the  18S fraction (see below). 
When we assessed the protein synthetic capacity of micro- 
somes  and  ribosomes  isolated  from a  number of treated 
preparations, we found that they showed a deficit similar in 
magnitude to the methylation defect (Table III). Since addi- 
tion of  poly(U) has been reported to stimulate protein synthe- 
sis by ribosomes isolated from CCl4-treated preparations, 
we examined the effects of poly(U) addition. We found that 
the restoration of protein synthetic capacity was highly vari- 
able and not reproducibly obtained, and was observed only 
with  isolated ribosomes  (this  may  reflect altered binding 
properties; see Discussion). Addition of poly(U) to micro- 
somal preparations was without significant effect (Table III). 
Our initial interpretation was that the decreased methyl- 
ation of cytoplasmic rRNA must reflect a defect in methyl- 
ation of nucleolar precursors (20-22, 29, 54, 56). We there- 
fore isolated nucleoli and extracted pre-rRNA from them. 
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Figure 2. Translatability of poly(A)  + RNA released into the SI00 
fraction after CC14 intoxication. CC14 was administered orally and 
rats were killed after various intervals. Poly(A)  + RNA was pre- 
pared from S100 fractions and equivalent amounts were translated 
in a standard in vitro protein synthesis assay. The increased translat- 
ability was significantly different from controls at 0.5 and 1 h after 
treatment.  Inset shows the translatability of S100 poly(A)  + RNA 
over 1-96 h after treatment; also shown is the lack of fluctuation 
of preparations after induction of the acute-phase response. Trans- 
lation of control poly(A)  + RNA yielded 48,000 cpm/Ixg. 
Our results seem inconsistent with a simple precursor-prod- 
uct relationship. In two sets of experiments, we observed in- 
creased methylation of nucleolar pre-rRNA in treated prepa- 
rations  (Table I).  Perhaps  more surprisingly,  the  specific 
activities of control nucleolar RNA were significantly lower 
than  those of cytoplasmic poly(A)- RNA  from the  same 
preparations in the absence of any "chase, while they were 
higher in treated nucleolar preparations (Table I). 
To examine the specificity of  this increased nucleolar RNA 
methylation, we subjected nucleolar RNA preparations from 
CCl4-treated  animals  to  enzymatic  digestion  and  HPLC 
separations.  The  observed methylation pattern  showed  a 
2'-O-ribose content (73.9 %), which was equivalent to that of 
control cytoplasmic poly(A)- RNA (or rRNA) digests (Fig. 
4). That is, the 2'-O-ribose methylation defect was not found 
in  treated  nucleolar pre-rRNA preparations.  We also  ob- 
served a significantly increased content of mTG, analogous 
to that noted in treated cytoplasmic preparations (Fig. 3, Ta- 
ble II), and a  somewhat lower percentage of m6A. 
We next isolated ribosomal subunits, incubated them with 
S100 fractions and [3H]AdoMet, and quantitated the radio- 
activity  incorporated  into  the  rRNA.  Incorporation  was 
significantly greater with treated preparations (Fig. 5), thus 
suggesting a  substantial  undermethylation of treated ribo- 
Table lI. Distribution of  lncorporated FH]Methyl Groups in Poly(A)- Cytoplasmic RNA 
Percent of incorporated  label in 
Sample  2'OmeC  2'OmeU  2'OmeG  2'OmeA  me6A  me6A  me7G 
Control  23.4  +  1.1  10.9  +  1.1  22.2  +  2.0  20.2  +  5.5  16.7  ___  3.5  4.2  +  1.6  2.3  +  0.5 
Treated  18.8  +  0.8  11.1  +  2.2  15.2  -I-  1.2  12.4  +  0.5  25.6  +  1.8  3.8  +  1.2  13.0  ___  2.0 
After treatments as described,  cytoplasmic poly(A)- RNA fractions were prepared,  digested to nucleosides, separated via HPLC,  and radioactivity corresponding 
to the methylated ribonucleosides was quantitated.  Analyses of individual preparations  showed an average of 76.7  +  4.8%  in 2'-O-ribose methylation in control 
preparations,  compared  with 57.6  +  3.5  in treated preparations. 
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Figure  3.  HPLC  analysis of nucleoside 
digests of cytoplasmic  poly(A)- RNA. 0.5 h 
after administration  of CCh  (or mineral 
oil),  rats were given  1.67 gCi[3H]methyl  - 
methionine. After a 1-h labeling, rats were 
killed and poly(A)- cytoplasmic RNA was 
prepared. The preparations were digested to 
uncharged  nucleosides,  and  separated  in 
HPLC  as described.  Inset shows percen- 
tages of radioactivity associated with the 
various  constituents.  A  marked  increase 
was noted in meTG, and also m6A. 
somes. Increased incorporation into treated 40S or 40 +  60S 
ribosomal  subunits  was  observed  with  either  control  or 
treated S100 fractions (Fig. 5). 
To assess the ability of S100 fractions to demethylate meth- 
ylated ribosomal subunits, ribosomes were prelabeled with 
[3H]AdoMet  in  vitro,  precipitated,  resuspended  in  S100 
fractions, and incubated for various periods of time. We ob- 
served a decline in methylation which was similar with both 
treated and control S100 fractions; the decline amounted to 
,o25 % under the conditions used. These data indicate that 
"demethylation" of ribosomal subunits proceeds at ,o20 % of 
the rate of methylation, and suggest that the net undermethy- 
lation of  treated ribosomes does not result from increased de- 
methylation of methylated rRNA. 
Undermethylated ribosomal subunits from treated prepa- 
rations were methylated in vitro with unlabeled AdoMet and 
their capacity to direct protein synthesis was measured and 
compared to control preparations treated similarly. Remeth- 
ylation of the treated ribosomal subunits resulted in signifi- 
cant increases in their synthetic capacity (Fig. 6) in an Ado- 
Met concentration-dependent manner; at the highest AdoMet 
concentration tested, treated subunits showed 97 +  8 % of the 
control activity. Similar remethylation of control prepara- 
tions was without significant change. 
In another series of experiments, the specificity of the in 
vitro methylation was examined (Fig. 7). With 40S and 60S 
ribosomal subunits from treated preparations, we observed 
a  considerable methylation at 2'-O-ribose positions,  most 
notably at G residues, along with a significant incorporation 
into m6A component, which is a well-described "late" cyto- 
plasmic methylation (2,  17, 41, 55). In contrast, while con- 
trol preparations also showed a prominent m6A component, 
there was  little or no labeling at 2'-O-ribose moieties. In- 
stead, most incorporation occurred at meTG. This methyl- 
ation corresponds to that observed in vivo with treated cyto- 
plasmic (Fig. 3) and nucleolar (Fig. 4) RNA preparations, 
although it was not observed in control preparations in vivo 
(in vitro methylation of control preparations did not appear 
to affect protein synthetic capacity). 
Discussion 
We have described a substantial undermethylation of ribo- 
somal RNA early after CCh intoxication that occurs con- 
currently with (or presages) the defect in the protein syn- 
thetic  capacity  of  isolated  ribosomes.  No  significant 
differences  in  methylation  of poly(A)  ÷  mRNA  or  small 
RNA fractions were found; further, these fractions appear to 
remain functional, as demonstrated by the in vitro translation 
of released mRNA (Fig. 2), suggestive of normal "capping" 
of mRNA (27), and the unchanged in vitro activities of the 
S100 fraction in supporting protein synthesis (Table HI). Fur- 
thermore, addition of poly(U) did not affect the protein syn- 
thetic capacity of isolated microsomal preparations (Table 
1/I).  Indeed, the apparent ability of poly(U) to restore the 
protein synthetic capacity of treated ribosomal preparations 
was highly variable, and probably reflects the greatly altered 
binding  capacity  of treated  preparations  (46).  Thus,  our 
findings with poly(U) also appear to localize the protein syn- 
thetic  defect produced  by  CCh  to  the  ribosomes  them- 
selves. 
Table III. Protein Synthetic Capacity of  Ribosomes 
after CCI4 Administration 
Incorporation of 
[~4C]phenylalanine 
(percent control) 
Sample  -  Poly(U)  + Poly(U) 
Experiment I 
Control  100 
Treated  53 
Experiment II 
Control  100 
Treated  49 
Microsome Source/S100 Source 
Control/control  100 
Control/treated  95 
Treated/control  48 
Treated/treated  36 
±  14  388  ±  100 
±  02  132  ±  05 
±  13  224  ±  30 
±  14  257  ±  50 
89 
111 
55 
44 
Rats were given 0.25 ml CC14 as described and killed  1 h later.  Ribosomes 
were prepared and in vitro protein synthesis was assessed using p*C]phenyl- 
alanine and control SI00 fractions (as described). Specific activities of incor- 
poration were 35-70 cpm/pg with control ribosomes, and 45 cpm/I.tg  with 
control  microsomes.  As  shown,  results  with  purified  ribosomes  without 
poly(U) were highly reproducible, but the results obtained with poly(U) were 
very inconsistent and variable. No significant differences were observed be- 
tween the ability of S 100 fractions from treated or control preparations to sup- 
port protein synthesis. 
The Journal of Cell Biology, Volume 105,  1987  708 250 
200  Z 
_o 
~  150 
u_ 
0 
50 
TREATED NUCLEOLAR RNA  2'0 meA 
2'0 meg  i l 
2'0 meC  ~  ', 
:~  2'0 meU  t  ~  merG 
¢'t,  !  ',  ~"~  imeA  m~A 
10  20  30  40  50  60  70  80  90  100  110  120  130  140  150 
FRACTION NUMBER 
Figure 4.  HPLC analysis  of nucleoside di- 
gest of  nucleolar RNA. Nucleolar RNA was 
labeled (as in Fig. 3), purified as described, 
digested  to nucleosides,  and analyzed via 
HPLC.  The  radioactivity associated  with 
the various 2'-O-ribose moieties was essen- 
tially identical to that found in control cyto- 
plasmic RNA preparations.  The increased 
meTG content noted (Fig. 3) was present in 
treated  nucleolar preparations,  and a pro- 
portional  decrease  in  m6A  labeling  was 
noted (m~A labeling  has been reported  to 
be largely cytoplasmic). 
For  both  quantitative  and  qualitative  reasons,  the  de- 
creased rRNA methylation we observed does not appear to 
result  from decreased  nucleolar methylation of pre-rRNA 
and  subsequent  rRNA  maturation.  Quantitatively,  treated 
nucleolar preparations show significantly greater specific ac- 
tivities  compared with control nuclear preparations.  Also, 
the much larger size of the cytoplasmic RNA pool makes it 
doubtful that most of the labeling could reflect maturation of 
unlabeled nucleolar RNA in the absence of a chase period, 
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even given the twofold larger size of the initial pre-RNA tran- 
script compared with 28/18S rRNA. Qualitatively, the 2'-O-ri- 
bose methylation defect was not present in the nucleolar pre- 
rRNA isolated from the same treated preparations (Fig. 4). 
When  intact  ribosomal  subunits  were  incubated  with 
[3H]AdoMet, we observed a significantly greater incorpora- 
tion of label into ribosomes from treated preparations (Fig. 
5).  This both substantiates  the notion that rRNA in treated 
preparations  is undermethylated,  and implies that the "un- 
dermethylated"  sites  are  exposed  on  the  surface  of  the 
subunits.  This supports previous studies which showed that 
about one-half of all 2'-O-methylation sites are exposed on 
the  surface of the  ribosomes  (12,  16),  and  studies  which 
document in vitro methylation of ribosomal subunits (13, 43, 
49, 52). Since preliminary experiments did not indicate any 
differences  in  demethylation  of  ribosomal  preparations 
(prelabeled in vitro) by S100 fractions from treated and con- 
trol  preparations,  our  results  suggest  that  the  net  under- 
methylation results from a defect in methylation of mature 
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Figure 5. In vitro methylation of  ribosomal subunits at various inter- 
ludes  after CCh intoxication.  Rats were given CCh (or mineral 
oil) and sacrificed  1.5 h later. Ribosomal subunits were isolated and 
resuspended in S100 fractions from treated or control animals with 
[3H]AdoMet.  After various  intervals,  aliquots  were precipitated 
with TCA collected on filters, rinsed extensively, and counted. The 
differences  in quantity of added S100 protein reflect titration  with 
individual  preparations.  Values shown are means -t- SE from three 
separate  preparations.  (A) Methylation of 40S ribosomal subunits 
in control SI00. 60 gg 40S subunits were incubated with 30 gg S100 
protein and [3H]AdoMet. (B) Methylation of 40 +  60S ribosomal 
subunits on control S100. 100 lag 40 + 60S subunits were incubated 
with 240 lag S100 protein and  [3H]AdoMet.  (C) Methylation  of 
40S ribosomal subunits  in S100 from treated  animals.  60 lag 40S 
subunits,  30 lag S100 protein.  (D) Time course of methylation  of 
40 +  60S ribosomal subunits in S100 from treated animals.  200 lag 
40  +  60S  subunits,  240  lag  S100 protein.  The  values  show  a 
significantly  increased  methylation  of ribosomal  subunits  from 
treated  preparations in both control and treated  SI00 fractions. 
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Figure  6.  Protein  synthetic  capacity  of 40  +  60S  ribosomal 
subunits  after  in  vitro  methylation  with  AdoMet.  Ribosomal 
subunits  were isolated and methylated  in vitro in the presence (or 
absence) of unlabeled AdoMet (1 x  =  170 laM AdoMet, 5 ×  =  850 
laM,  10x  =  1.7 mM). After 40 min, reactions were diluted  and 
chilled to 4°C, and the ribosomal subunits were harvested  by cen- 
trifugation.  The subunits  were then assessed  for protein synthesis 
in  the  presence  of  control  S100 fractions  as  described.  No 
significant differences were noted in control preparations incubated 
with or without AdoMet.  The differences  observed with treated 
preparations were significant with either Ix, 5x, or 10x AdoMet 
(compared with treated  preparations incubated  without AdoMet); 
the protein synthetic  capacity of treated  preparations  methylated 
with 5 x  AdoMet was not significantly  different  from concurrent 
control preparations  incubated  similarly.  There was nearly 100% 
restoration  of protein synthetic capacity of treated  ribosomal sub- 
units after in vitro methylation with 10x AdoMet (97 -t- 8% of that 
for similarly incubated  control preparations). 
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Figure  7.  HPLC  analysis of nucleoside 
digests of ribosomal subunit RNA after in 
vitro methylation with [3H]AdoMet. Puri- 
fied 40S and 60S ribosomal subunits from 
treated or control preparations were incu- 
bated  with  10x  [3H]A_doMet (250  BCi) 
with control S100 fractions for 30 min at 
37°C.  The mixtures  were  then  extracted 
with chloropane and the aqueous phase was 
precipitated twice with ETOH. The pelleted 
RNA was then digested and examined via 
HPLC. 
Treated preparations, which showed re- 
stored functional activity, showed methyl- 
ation at the 2'-O-ribose positions, mostly at 
G residues, along with considerable meth- 
ylation as mrA, which is a well described "late" cytoplasmic methylation. There was no labeling of meTG in treated preparations (presum- 
ably because me7G methylation occurred in vivo). In contrast, there was no significant labeling of 2'-O-ribose positions in control prepara- 
tions (these are apparently fully methylated in vivo), whereas there was a marked labeling of me7G along with m26A. The significance of 
methylation at meTG is not clear, although it does not appear to affect protein synthetic capacity. 
ribosome RNA (subunits), presumably in the cytoplasm (al- 
though the defect cannot be attributed to S100 fractions). In 
this regard, "late" cytoplasmic methylations of rRNA have 
been described (2,  17, 41, 55), but they largely involve base 
methylations, which are relatively unaffected here. Further- 
more,  dimethylation of A  residues  (m26A) is  a  prominent 
component of the in vitro methylation we observed (Fig. 7). 
The bases for resistance to various antibiotics have been 
ascribed to differences in methylation of  rRNA (13, 18, 31-33, 
43, 49, 52). In some instances the defects are associated with 
altered  interactions  between  the  subunits  (31-33),  and  a 
specific conserved methylated sequence has been implicated 
(7,  13,  31-33, 52).  The methylation defects have generally 
been associated with defects in rRNA  maturation (18, 28, 
35), although uncoupling of methylation and processing may 
occur (5,  15). However, comparison studies on methylation 
of nucleolar vs.  cytoplasmic rRNA,  in  general,  reflect a 
steady state look at the populations.  Our results suggest a 
turnover of late cytoplasmic methylations in hepatocytes, 
which is selective for exposed 2'-O-ribose moieties. In this 
regard,  the late methylation in mRNA caps occurs in the 
cytoplasm and involves a 2'-O-methylation (30, 42), although 
internal merA methylations may participate in processing 
reactions (14). Furthermore, our data suggest the functional 
importance of the methylation, because 2'-O-methylation of 
undermethylated  ribosomal  subunits  largely  restores  the 
functional deficit. 
We therefore suggest, in rat hepatocytes, that (a) an impor- 
tant component of ribosome function involves a continuous 
cytoplasmic methylation/demethylation of 2'-O-ribose sites 
exposed on the surface of  mature ribosomal subunits, and (b) 
CCh treatment disrupts protein synthesis by inhibiting cyto- 
plasmic 2'-0 methylations at a very early stage in cellular in- 
jury. Teleologically speaking, just at the time that the cell 
must respond to toxic injury by increasing protein synthesis 
to replace damaged components, the ribosomes are com- 
promised functionally by undermethylation. 
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